A New Way to Rip Off the Taxpayer
I often mention how “impressed” I am by the ingenuity of fraudsters and their ability to find new and creative ways to steal money. And now, with the country starting to pay attention to the opioid crisis, comes word of one of these fraud innovations. This time, fraud (and to be fair, often just massive waste) is found in the escalating number of urine tests being performed to detect opioids and other drugs in patients.
Kaiser Health News, with help from the Mayo Clinic, found billing for urine screens and related tests quadrupled from 2011 to 2014 to $8.5 billion a year. The federal government paid providers more for drug urine screens than they paid for the four most common types of cancer screens combined. $8.5 billion is more than the annual budget of the Environmental Protection Agency!
It’s easy to see how this could happen. In the cases of 50 less-than-scrupulous doctors who operate their own labs, Medicare paid over $1 million for drug tests at their pain management practices. 31 of these received over 80 percent of their Medicare payments from urine tests—in other words, less than 20 percent was for patient care!
Other labs have hired sales team that employ high-pressure tactics, telling doctors to order more tests to lower patients’ risks and to protect their practices against law enforcement or medical licensing board investigations. One labs sales manager earned $700,000 in salary and commissions, and the company later had to pay $256 million to settle claims with the justice department.
While some of the data in this blog post is over two years old, opioid prescriptions (and deaths) continue to climb—the latter at about 20 percent per year. Despite the government’s enforcement efforts, I assume that the urine test cash grab is also accelerating. It’s also safe to assume that when this scheme is shut down, the fraudsters will find another way to rip us off.